Determination of proton affinities and pKa values of small organic molecules
Calculate acidity and basicity of small drug molecules
Calculate acidity and basicity of small drug molecules
The Sponsor intended to have a bio-predictive media followed by IVIVR model to predict the plasma exposure for different in-vitro release and different doses. The Sponsor had performed a pre-clinical study on the higher strength.
Could Modeling and Simulation predicts the Human BE outcome without conducting actual BA BE study?
Pre-clinical BA BE data of the test product and the reference were used in the analysis.
The in silico BE predictions were done by means of IVIVC modeling followed by virtual BE
A validated IVIVC model (see figure) was developed and used to simulate the “BE outcome”.
| Drug Record | Cmax (ng/mL) | AUC (ng/mL*h) | ||||
| Obs. | Pred. | % Pred. Error | Obs. | Pred. | % Pred. Error | |
| Microspheres (LAI) | 3.72 | 3.39 | 8.87 | 1110 | 1005 | 9.45 |
The M&S methodology for IVIVR model building predicted the BE outcome for different in-vitro release profiles.
The Sponsor reduced costs and timelines by decreasing the development timeline and number of clinical studies
Designing and searching effective drug molecules for various diseases
Calculate acidity and basicity of small drug molecules
In silico Quantitative Structure-Toxicity Relationship (QSTR) Model for Predicting Toxicity of Aromatic Aldehydes using Extended Topochemical Atom (ETA) Indices.
Connect with our in silico team of experts to discuss AI solutions and advanced modeling and simulation for the Pharma and Life Science industries and hyper accelerate your success
Our Locations
Copyrights 2024 Ikiminds Pvt Ltd. All Rights Reserved